Bicycle Therapeutics plc (BCYC)

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	457	526.42	339.15	438.68	135.99	92.12
Cash & Cash Equivalents	457	526.42	339.15	438.68	135.99	92.12
Cash Growth	55.54%	55.22%	-22.69%	222.58%	47.63%	45.34%
Receivables	39.06	24.04	21.21	11.91	14.63	7.15
Other Current Assets	19.9	11.41	9.02	7.97	5.1	4.88
Total Current Assets	515.96	561.87	369.38	458.56	155.72	104.15
Property, Plant & Equipment	24.81	27.68	32.77	17.79	3.61	4.35
Other Long-Term Assets	6.37	5.79	8.46	3.45	1.82	1.7
Total Long-Term Assets	31.18	33.48	41.23	21.24	5.43	6.05
Total Assets	547.14	595.34	410.61	479.79	161.15	110.19
Accounts Payable	7.06	13.05	6.47	2.72	1.37	1.95
Deferred Revenue	114.55	135.19	61.87	71.34	35.16	5.66
Other Current Liabilities	-72.1	-78.71	-15	-37.82	-13.39	1.22
Total Current Liabilities	49.51	69.54	53.34	36.24	23.13	8.82
Long-Term Debt	38.85	40.08	41.2	41.95	14.93	1.25
Other Long-Term Liabilities	102.74	114.8	45.28	55.35	27.63	6.92
Total Long-Term Liabilities	141.59	154.88	86.48	97.3	42.56	8.18
Total Liabilities	191.1	224.41	139.83	133.54	65.69	17
Total Debt	38.85	40.08	41.2	41.95	14.93	1.25
Debt Growth	-13.30%	-2.72%	-1.80%	180.99%	1093.53%	-
Retained Earnings	-538.32	-511.76	-331.1	-218.38	-151.56	-100.55
Comprehensive Income	-0.78	-1.3	0.39	-3.39	-3.19	-1.54
Shareholders' Equity	356.05	370.93	270.78	346.25	95.46	93.2
Net Cash / Debt	418.15	486.34	297.95	396.73	121.06	90.87
Net Cash / Debt Growth	67.93%	63.23%	-24.90%	227.71%	33.23%	43.37%
Net Cash Per Share	9.82	13.66	10.05	15.83	6.32	8.23
Working Capital	466.45	492.33	316.04	422.32	132.59	95.33
Book Value Per Share	8.37	10.42	9.13	13.82	4.99	8.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).